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Background: Prior reported cases of stillbirth and neonates infected with enteroviruses suggest transplacental
infection. We present a case of fetal infection with coxsackievirus B3, diagnosed antenatally and resulting in live
birth.
Case: A pregnant woman presented at 26 weeks with fetal tachycardia and non-immune hydrops fetalis.
Coxsackievirus B3 was cultured from amniotic ﬂuid. Maternal antibody to coxsackievirus B3 was positive at 1:
512. At 32 weeks, the fetus deteriorated and was delivered. Cord blood antibody to coxsackievirus B3 was
positive at a higher titer. Following neonatal death, brain and placental tissues were positive for enterovirus
ribonucleic acid by polymerase chain reaction.
Conclusion: Intrauterine infection by enteroviruses should be considered in the differential diagnosis of non-
immune hydrops fetalis. Antenatal diagnosis of coxsackievirus B3 infection is associated with poor outcome.
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PRE ´CIS
Intrauterine infection by enteroviruses is part of
the differential diagnosis of non-immune hydrops
fetalis, and is associated with poor prognosis.
INTRODUCTION
Enteroviruses, which include coxsackieviruses
and echoviruses, are distributed worldwide and
cause infections, which are more prevalent
during the summer and early fall in temperate
climates. Coxsackieviruses usually produce rela-
tively mild symptoms in adults, although
myocarditis and encephalitis are well recognized
complications. Enterovirus infection of the hu-
man neonate is an unusual but serious event,
which rivals neonatal herpes simplex virus
infection in incidence and severity. Numerous
reports of cases and epidemics can be found in
the literature, documenting the morbidity and
mortality associated with enteroviral infection in
neonates
1. However, transplacental infection and
associated fetal morbidity and mortality have not
been well documented. Detection of the virus
has been reported in stillbirth infants at autopsy
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newborns with neurodevelopmental delays
2.
Antenatal enterovirus infection due to cox-
sackievirus B1 and echovirus types 11 and 27, has
previously been isolated from amniotic ﬂuid in
the third trimester of pregnancies, with poor early
neonatal outcome, supporting probable transpla-
cental passage. Coxsackievirus B3 has been
diagnosed in a stillborn infant with myocarditis
and hydrops fetalis
3. Post-natal diagnosis of
coxsackievirus B3 has been made from congenital
skin lesions
4. We present a case of intrauterine
infection by coxsackievirus B3 diagnosed antena-
tally, resulting in live birth.
CASE REPORT
At a regular prenatal visit, a 34-year-old Cauca-
sian presented at 26 weeks gestation with fetal
tachycardia of 175 beats per minute. The
pregnancy had otherwise been uneventful. Two
previous ultrasounds, at 7 and 19 weeks, were
reported as normal. There was no history of
febrile illnesses during the pregnancy. The patient
had previously delivered a normal term baby,
vaginally. Her past medical and surgical history
was unremarkable. Her blood group was O
positive with a negative antibody screen. The
patient was not taking any medication, did not
smoke, drink alcohol or use illicit drugs.
An ultrasound showed a fetal hydrops with
signiﬁcant ascites and a small pericardial effusion.
Mild scalp and thoracic skin edema were present
without pleural effusion. No structural fetal
anomalies were noted. The fetal biophysical
proﬁle was 8/8. The umbilical artery Doppler
was normal, as was the middle cerebral artery
peak systolic velocity.
Fetal echocardiography showed no obvious
structural cardiac abnormalities. A fetal heart rate
(FHR) of 165–175 beats per minute with 1: 1
atrioventricular conduction was conﬁrmed. Fre-
quent premature atrial contractions with several
brief runs of supraventricular tachycardia (rate
245–260 beats per minute) were observed.
Decreased ventricular function (ejection fraction
20–25%)withsmallpericardialeffusionwasnoted.
A bright-walled atrium without evidence of
ventricular endocardial ﬁbroelastosis was viewed.
Diagnostic amniocentesis was performed. The
fetal karyotype was 46 XY. Serological testing for
toxoplasma, rubella, parvovirus B19, cytomega-
lovirus, inﬂuenza and Epstein-Barr virus did not
indicate an acute infection. HIV serology was also
negative. Maternal therapy with Digoxin 500
mcg BID and Sotalol 80 mg BID was started to
control the tachyarrythmia. Betamethasone was
administrated prophylactically to accelerate fetal
lung maturity.
Following a week of antiarrythmic therapy
within the therapeutic range, the fetal status
remained unchanged. A diagnostic cordocentesis
demonstrated a fetal hemoglobin at 11 gm/dL,
hematocrit 32%, MCV 133.7 fL and mild
thrombocytopenia 99,000/mm
3. The fetal hepa-
tic and renal function tests were normal.
The amniotic ﬂuid was subsequently reported
as culture positive for an enterovirus, although it
was negative for enterovirus RNA by nucleic acid
sequence-based ampliﬁcation (NASBA; bioMe ´r-
ieux Inc.), and negative for parvovirus B19 DNA
by polymerase chain reaction (PCR). The
enterovirus isolate was sent to the National
Centre for Enteroviruses (NCEV) in Halifax,
Canada and was typed as a coxsackievirus type B,
group 3 (B3). Maternal cultures of stool and
throat washings were negative for enteroviruses.
Maternal serum obtained at initial presentation
contained neutralizing antibody to coxsackievirus
B3 at a titer of 1: 512 (NCEV). A repeat serum
taken 3 weeks later remained positive for anti-
body to coxsackievirus B3 at the same titer.
The mother was kept on Sotalol, and the fetal
heart rate normalized at 155 beats per minute,
with minimal variability on the fetal heart
monitoring. The fetal hydropic status remained
unchanged. The infection status, the suspected
poor fetal prognosis and the limited therapeutic
options were discussed with the parents.
At 32 weeks gestation, the fetus developed
oligohydramnios, bilateral pleural effusion, and
worsening of the abdominal ascitis with a low
biophysical proﬁle score of 4/8. A male infant, in
breech presentation, was delivered with Apgar
scores of four, six and eight at 1, 5 and 10 minutes
respectively. The birth weight was 2380 g.
Umbilical artery cord gas showed pH: 7.33; PO2
42; PCO2 19.8 and HCO3 21.9. Anasarca was
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and the initial heart rate was less than 80 bpm. The
infant was resuscitated with positive pressure
ventilation and intubation. Initial physical exam
revealed a grossly edematous male infant with
marked centraledema. There were no dysmorphic
features or obvious congenital anomalies.
Paracentesis yielded 30 ml, and thoracentesis
produced 11 ml of sero-sanguinous ﬂuid. The
initial hemoglobin was 11 gm/dL, platelets were
65,000/mm
3 and white cell count was 4.2/mm
3.
Coagulation studies revealed at partial trombo-
plastine time of 46 and an international
normalization ratio of 1.46. Packed red blood
cells, platelets and fresh frozen plasma were given.
There were no arrhythmias recorded at or around
the time of delivery. Dopamine was initiated to
enhance renal perfusion. The infant remained
ventilator-dependent with high oxygen needs. An
early echocardiogram revealed signiﬁcant systolic
dysfunction with a shortening fraction of 25%. It
also revealed severe diastolic dysfunction with stiff
atria and ventricles. There was evidence of hepatic
dysfunction with elevated coagulation studies and
decreased albumin, despite fresh frozen plasma,
vitamin K and albumin infusions. The infant
became anuric after the ﬁrst 24 hours of life.
PCR for Herpes group viruses and entero-
viruses and viral cultures of the infant’s blood,
pleural, ascitic, and cerebrospinal ﬂuids were
negative. Cord blood obtained at birth demon-
strated a neutralizing antibody titer to coxsackie-
virus B3 of 1: 16384 (NCEV). With prenatal
detection of the speciﬁc viral pathogen, the infant
was treated with Pleconaril as an emergency
release medication as this antiviral drug has not
been approved in Canada. With evidence of
multiorgan failure, on the fourth day of life,
therapy was withdrawn and the baby expired.
The autopsy revealed a hydropic baby without
gross anomalies. Cardiac pathology included a
mild right ventricular hypertrophy, biventricular
dilatation and two small foci of calciﬁcations
(right ventricule and atrioventricular groove).
The neuropathological evaluation did not reveal
any evidence of viral involvement. The placenta
was hydropic and displayed dysmature villi. There
was mild microscopic meconium staining of the
membranes, small areas of infarcts and ﬁbrin, but
no evidence of any acute or chronic placental
inﬂammation. Although viral cultures were all
negative, PCR (Chemicon International) for
enterovirus RNA was positive from brain and
placenta tissues, and negative for the other tissues
(lung, spleen, liver, kidney, and heart).
DISCUSSION
Despite reports of intrauterine transmission of
enteroviruses in animals
5, vertical transmission in
humans is not well accepted. This report presents
a case of intrauterine coxsackievirus B3 infection
diagnosed during the second trimester with non-
immune fetal hydrops, resulting in a live birth
and subsequent early neonatal death, secondary
to multiorgan failure. A case of coxsackievirus
B3 reported in 1970
6 describing a stillborn
hydropic fetus appears similar to our case,
supporting the transplacental passage and the
poor outcomes associated with this type of
intrauterine infection. Other cases of stillbirth
with post-natally diagnosed enteroviral infection
have been reported in the literature
7. Euscher et
al. recently reported cases of placental infection
with coxsackievirus, possibly resulting in ence-
phalitis with subsequent neurological damage in
the newborn
2. We were able to detect the
presence of enteroviral RNA in both brain and
placental tissue, supporting the ﬁndings of that
study. Our case also demonstrates that transpla-
cental infection by enteroviruses in humans does
occur, as does the potential for diagnosing it
prenatally. Coxsackieviruses and other entero-
viruses can cause myocarditis, and therefore,
intrauterine infection with enteroviruses should
be considered in the differential diagnosis of
non-immune hydrops fetalis.
In adults most infections due to enteroviruses
are asymptomatic, as was seen in our case. A non-
speciﬁc febrile illness with or without a rash may
occasionally be present. Other less commonly
encountered clinical manifestations of enteroviral
infections include encephalitis, aseptic meningitis,
pericarditis and myocarditis. The antenatal diag-
nosis was made by a positive culture of the
amniotic ﬂuid, although there was a false-negative
NASBA result. Nucleic acid ampliﬁcation tests
(NAAT) such as PCR and NASBA are now
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virologic diagnosis, but there are some limitations.
Despite the reported enhanced sensitivity of many
of these new molecular assays over enterovirus
culture, most of the published evaluations have
involved the testing of cerebrospinal ﬂuid rather
than amniotic ﬂuid
6. The viral RNA may
degenerate more easily in amniotic ﬂuid or there
may be inhibitors present. In our case, the culture
of the amniotic ﬂuid was performed in addition to
NASBA. This led to maternal diagnosis, which
was supported by the positive serology results.
Infection of the infant was suspected by the
higher titers of antibodies found in the cord blood
(we could not exclude that the cord antibodies
could be of maternal origin), and conﬁrmed by
the presence of enteroviral RNA in brain and
placenta tissues at autopsy. Nucleic acid ampliﬁ-
cation methods such as PCR have a lower limit of
detection than viral cultures, which would
explain why the autopsy tissues were PCR
positive but culture negative. Also, as previously
reported, viral infections of the placenta are
associated with several non-speciﬁc histologic
ﬁndings ranging from focal to diffuse. Such
viruses may require extensive sampling to be
detected, which accounts for the non-speciﬁc
histologic results on the placenta in our case.
Prenatal diagnosis of intrauterine infection
leads to increased opportunity for fetal therapy.
The empiric treatments proposed for neonates
infected with enteroviruses have included com-
bined therapy of intravenous gamma or
hyperimmune globulin and leukocyte interferon
8.
This has not been reported for in utero therapy,
and there is no evidence that such treatments will
prevent the fatal outcome of disease. Speciﬁc
antiviral therapy such as Pleconaril shows promise
in the treatment of meningitis and other life
threatening infections due to enteroviruses.
However, the safety or efﬁcacy of this drug
during pregnancy is unknown. Given the poor
fetal prognosis, it would seem appropriate to
discuss this antiviral treatment option with the
parents. The results of on-going studies of
Pleconaril may determine what role, if any, this
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